Briumvi 25 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
7680695990010
CH-69599
Konzentrat
Associated product:
BRIUMVI 25 mg/ml / 150 mg / 1 flacon(s)
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
31.57 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2338.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2025
Authorization holder
Neuraxpharm Switzerland AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 69599
- Drug name
- Briumvi, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG14
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 06/02/2025
- Authorization expiration date
- 05/02/2030
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- BRIUMVI 25 mg/ml / 150 mg / 1 flacon(s)
- Description (DE)
- BRIUMVI 25 mg/ml / 150 mg / 1 Durchstechflasche(n)
- Market launch
- 01/07/2025
- Narcotic (BTM)
- No
Other package sizes (1)
BRIUMVI 25 mg/ml / 150 mg / 3 flacon(s)
3 DUR
GTIN: 7680695990027